For patients with unresectable or disseminated ALK-positive histiocytosis, therapy with ALK inhibitors has demonstrated considerable efficacy.<h4>Case presentation</h4>An 8-month-old Chinese male infant was admitted with 1-day history of fever and newly diagnosed anemia of 0.5-day duration. The gene discussed is ALK; the disease is anemia (phenotype).